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Introduction: Despite much research, interventions to improve medication adherence
report disappointing and inconsistent results. Tailored approaches that match
interventions and patient determinants of non-adherence were seldom used in clinical
trials. The presence of a multitude of theoretical frameworks and models to categorize
interventions and patient determinants complicated the development of common
categories shared by interventions and determinants. We retrieved potential interventions
and patient determinants from published literature on medication adherence, matched
them like locks and keys, and categorized them according to the Theoretical Domains
Framework (TDF).
Methods: We identified the most relevant literature reviews on interventions
and determinants in a pragmatic literature search, extracted all interventions and
determinants, grouped similar concepts to umbrella terms and assigned them to TDF
categories. All steps were finalized in consensus discussion between the authors.
Results: Sixteen articles (5 with determinants, 11 with interventions) were included
for analysis. We extracted 103 interventions and 42 determinants that we divided
in 26 modifiable and 16 unmodifiable determinants. All interventions and modifiable
determinants were matched within 11 categories (Knowledge; Skills; Social/professional
role and identity; Beliefs about capabilities; Beliefs about consequences; Intentions;
Memory, Attention and decision processes; Environmental context and resources; Social
influences; Emotion; and Behavioral regulation).
Conclusion: In published trials on medication adherence, the congruence between
interventions and determinants can be assessed with matching interventions to
determinants. To be successful, interventions in medication adherence should target
current modifiable determinants and be tailored to the unmodifiable determinants.
Modifiable and unmodifiable determinants need to be assessed at inclusion of
intervention studies to identify the patients most in need of an adherence intervention.
Our matched categories may be useful to develop interventions in trials that investigate
the effectiveness of adherence interventions.
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INTRODUCTION
After 4 decades of research on adherence to medication, the
progress is disappointing and adherence remains a fragmented
construct. Medication adherence is briefly defined as the
behavioral response to an agreed medical recommendation
(Sabaté, 2003) and is measured either dichotomously (either one
is adherent, or one is not) or continuously. Recently, medication
adherence has been defined to consist of three different phases:
initiation, implementation, and persistence (Vrijens et al., 2012).
Non-adherence is not simply the reverse of adherence. Two
patients can be equally non-adherent with respect to measuring
adherence, for example take only 60% of their pills. At the same
time, the reasons for these patients to be non-adherent may vary
widely.
The complexity of the characteristics of adherence was already
known by the end of the 1970s (Becker and Maiman, 1975).
Despite much research in the 1980s and 1990s, few new insights
arose. Research in the 1990s emphasized the influence of patient
beliefs about health in general and about illness/medication in
particular (Horne and Weinman, 1999). Qualitative research
on patients’ perspectives started with the new millennium and
identified new issues like the quality of the doctor-patient
relationship and patient health beliefs (Vermeire et al., 2001).
Grossly, five theoretical approaches could be identified that all
view non-adherence from a different perspective (Leventhal and
Cameron, 1987). The oldest approach is the biomedical model
that focuses on dispositional characteristics of the patient such as
demographic or personality traits. Operant behavior and social
learning theories shifted the focus to the behaviors needed for
adherence. In the communication model, the patient seeks expert
advice and treatment from the healthcare professional; adherence
results from persuasion through effective communication. The
rational decision-health belief and reasoned action model
generated the patient’s perception of risk and motivation for
action. Finally, the self-regulative systems theory sees the patients
as an active problem solver. Extent and factors of non-adherence
have been extensively investigated, and a plethora of strategies
to improve adherence was developed, mostly without consistent
success (Haynes et al., 2008).
A systematic review of reviews analyzed interventions with
regard to theoretical models and found no clear correlation
between the effectiveness of interventions that were theory-
based and those without an explicit theoretical background (van
Dulmen et al., 2007).
The most recent approach, the Theoretical Domains
Framework (TDF), was developed to integrate the various
behavior change theories. It aimed to simplify the investigation
of behavioral problems such as adherence and to facilitate
intervention design (Cane et al., 2012).
Success in a complex process like adherence can only be
achieved with the integration of many ingredients, and a single
obstruction causes failure. This concept is sometimes referred
to as the “Anna Karenina principle,” referring to the first
sentence in Tolstoy’s novel Anna Karenina: “Happy families
are all alike. Every unhappy family is unhappy in its own
way.” In this regard, it takes one deficient factor to cause
non-adherence. Therefore, the purpose of any intervention
strategy should be to compensate for each reason causing non-
adherence. As acknowledged by others (Hugtenburg et al.,
2013; Linn et al., 2013; Müller et al., 2015), it seems thus
obvious that a tailored approach is required, i.e., an approach
that adapts the keys (interventions) to the locks (patient
determinants).
Various attempts to categorize interventions ended up with
coarse sections like educational, behavioral, social, and mixed
forms (Kripalani et al., 2007) or simple groupings (Haynes
et al., 2005). In the field of behavior change research, a
recent international consensus developed a framework (the
Behavior Change Technique Taxonomy) with 93 behavior change
techniques clustered in 16 groups (Michie et al., 2013). Although
not specific for medication adherence, the new taxonomy has
been used to classify interventions in the field of adherence
research (Joost et al., 2014). As behavior change is only one aspect
of medication adherence, this unilateral framework appears
limited to categorize the sum of all adherence interventions.
A broader view on adherence was captured by a Cochrane
Review on interventions to improve safe and effective medicines
use (Ryan et al., 2014). Interventions were grouped in eight
categories: Providing information or education; Facilitating
communication and/or decision making; Acquiring skills and
competencies; Supporting behavior change; Support; Minimizing
risks or harms; Improving quality, and Consumer system
participation.
Patient determinants of non-adherence were often categorized
according to the five dimensions of non-adherence proposed by
WHO (Sabaté, 2003) or variations of these concepts (Baudrant-
Boga et al., 2012): Social- and economic-related factors; Health
system/health care team-related factors; Therapy-related factors;
Condition-related factors, and Patient-related factors.
Matching possible targets for medication adherence to the
types of interventions will yield more insight in effective
strategies able to overcome the different barriers for medication
adherence. To our knowledge, common categories shared by
interventions and patient determinants of non-adherence have
never been proposed. As a result, interventions for improving
adherence and patient determinants were seldom matched in
clinical trials. As an example, from 109 studies aimed at
improving patient adherence, only 13% reported the assessment
of patient determinants at baseline (Haynes et al., 2015). Even
though some studies reported tailoring of interventions to patient
characteristics, the specific procedure remains often unclear and
thus, the results are almost impossible to replicate (Haynes et al.,
2015).
In this article, we retrieved potential interventions and patient
determinants from published literature on medication adherence
and aimed at matching them like locks and keys.
GOALS/AIMS
• To extract from literature salient (a) interventions intended
to improve adherence and (b) related patient determinants of
non-adherence.
• To categorize the retrieved (a) interventions and (b)
determinants.
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• To match (a) and (b).
METHODOLOGY
Search Strategy
Several recent systematic literature reviews exist on interventions
and patient determinants of non-adherence. It seemed
superfluous to repeat this process and thus, we abstained from
a systematic literature search with broad major/MeSH terms
such as “patient compliance.” Rather and in order to identify
literature with the highest relevance to our aims, we pursued
a pragmatic search strategy to identify existing reviews with
the terms “intervention” and “determinant” or “factor” which
are widely used in conjunction with medication adherence.
We combined these specific terms with the established terms
“adherence” or “compliance.”
We searchedMedline via Pubmed onMarch 10, 2015 (without
time limits) with the following terms and a limit set to reviews:
a) intervention∗[title] AND (improv∗[title] OR enhanc∗[title])
AND medication[title] AND (adherence[title] OR
compliance[title]).
b) (determinant∗[title] OR factor∗[title]) ANDmedication[title]
AND (adherence[title] OR compliance[title]).
Titles and abstracts of the search results were screened for
relevance by two investigators (SA, IA). To assure a generic
view on medication adherence (not restricted to specific diseases,
medications or settings), we excluded full-text articles when they
investigated:
• single conditions
• single medication groups
• specific providers
• specific target groups
• single intervention
• economic evaluations
• specific adherence measurement methods.
Data Extraction and Processing
All extractions were performed in MAXQDA 11 (VERBI GmbH,
Berlin, Germany). All steps were performed separately for
interventions and determinants.
In the first step, IA and SA reviewed full-texts from the
included articles. Both investigators independently extracted
items of (a) interventions and (b) determinants for non-
adherence and scanned the reference list for additional articles.
Investigators were not blinded with regard to authors or journal.
The lists were reviewed by both investigators in a consensus
discussion and umbrella terms were introduced for items with
similar connotations.
In the second step, IA and SA independently matched each
intervention to individual determinants. Items that did notmatch
were listed separately.
In the third step, IA and SA assigned the matched
interventions and determinants to the 14 domains of the TDF.
We chose the TDF because it offers the most recent framework,
combines various theoretical models, and has a strong empirical
base. We determined consistency among raters performing an
interrater reliability analysis using the Kappa statistic.
Disagreements were resolved by discussion until consensus
was reached (first and second steps) or by an adjudicator (third
step).
FIGURE 1 | PRISMA flow diagram (Moher et al., 2009) for study selection process.
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RESULTS
Literature Search
A total of 65 articles were obtained (Figure 1). Two articles were
updated versions of previous Cochrane analyses (Haynes et al.,
2008; Schedlbauer et al., 2010). Screening of the reference lists
yielded two additional articles that were included in the review
(Vermeire et al., 2001; Ryan et al., 2014). Five articles were
excluded after screening of titles and abstracts because they were
not relevant to our aims. After full-text screening, 44 articles
were excluded because they investigated (a) single conditions (18;
schizophrenia, psychiatric disorder, transplantation, diabetes,
hypertension, Parkinson, inflammatory bowel, rosacea); (b)
single medication groups (14; antidepressant, cardiovascular,
heart failure, antipsychotic, osteoporosis, hypoglycemic and
lipid lowering agents); (c) specific providers (4; pharmacist,
physician, nurse); (d) specific target groups (1; children);
(e) single intervention (4; HIT, technology-mediated, cultural
responsive, electronic reminders); (f) economic evaluations (2);
(g) adherence measurement methods (1; electronically compiled
drug dosing history).
The final set included 16 articles (11 with interventions, 5 with
determinants, Table 1).
We extracted 103 different interventions, including variations
of the same concept such as different forms of reminders. We
extracted 42 determinants that we divided into 26 modifiable
and 16 unmodifiable determinants. We defined modifiable
determinants as factors that may be changed by interventions
(such as knowledge or behaviors) and unmodifiable determinants
as those that are unchangeable (such as age). Some unmodifiable
determinants may appear modifiable at first sight, such as
level of education or employment situation. However, those
determinants are not targeted by the adherence interventions,
albeit they may influence the choice of an appropriate
intervention. Thus, unmodifiable determinants (Box 1) were not
included in the matching procedure.
Matching Procedure
From the original 14 domains of the TDF, 11 suffice to
categorize our 103 interventions and 26 modifiable determinants
(Table 2). No intervention or determinant could be assigned to
the three original domains “Optimism,” “Reinforcement,” and
“Goals.” Because heterogeneous interventions and determinants
were included in the domain “Environmental context and
resources,” we created the subdomains “Regimen,” “Adverse
events,” “Integration and coordination of care,” and “Financial
aspects” (Table 3).
The interrater reliability was substantial with a Cohen’s Kappa
of 0.7 (95% CI 0.5–0.9, p < 0.001).
DISCUSSION
Based on a literature review, we were able tomatch 103 adherence
interventions and 26 patient determinants within 11 common
categories. The fact that interventions were more diverse than
patient determinants is not surprising, as there is usually more
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BOX 1 | UNMODIFIABLE DETERMINANTS OF NON-ADHERENCE
• Age (Vlasnik et al., 2005; Ingersoll and Cohen, 2008; Schäfer-Keller et al., 2010; Baudrant-Boga et al., 2012)
• Gender (Vlasnik et al., 2005)
• Level of education (Vlasnik et al., 2005; Ingersoll and Cohen, 2008) (literacy)
• Employment situation (Vlasnik et al., 2005)
• Financial situation (Vlasnik et al., 2005; Baudrant-Boga et al., 2012) (socioeconomic status, lack of insurance, income, material resources)
• Insurance type/coverage (Zeber et al., 2013)
• Ethnicity and culture (Vlasnik et al., 2005; Schäfer-Keller et al., 2010; Baudrant-Boga et al., 2012; Zeber et al., 2013) (language difficulties, race, immigration status)
• Housing situation/living situation (Vlasnik et al., 2005; Baudrant-Boga et al., 2012; Zeber et al., 2013) (lack of fixed address, living alone, marital status)
• Cognitive impairment (Vlasnik et al., 2005; Ingersoll and Cohen, 2008; Baudrant-Boga et al., 2012)
• Illness chronicity (Zeber et al., 2013)
• Illness severity (Vlasnik et al., 2005; Schäfer-Keller et al., 2010; Baudrant-Boga et al., 2012; Zeber et al., 2013) (absence, reduction, disappearance or fluctuation
of symptoms)
• Polymorbidity (Zeber et al., 2013)
• Change of therapy (Vlasnik et al., 2005; Schäfer-Keller et al., 2010)
• History of non-adherence (Vlasnik et al., 2005)
• Past treatment response (Zeber et al., 2013)
• Duration of treatment (Schäfer-Keller et al., 2010; Baudrant-Boga et al., 2012).
TABLE 2 | Final 11 categories of the TDF with corresponding definitions sufficient to categorize interventions and patient determinants.
Category Interventions and determinants focusing on ...
1. Knowledge ... the awareness of the existence of something
2. Skills ... the ability or proficiency acquired through practice
3. Social/professional role and identity ... behaviors and displayed personal qualities of an individual in a social or work setting
4. Beliefs about capabilities ... the acceptance of the truth, reality, or validity about an ability, talent, or facility that a person can put to constructive use
5. Beliefs about consequences ... The acceptance of the truth, reality, or validity about outcomes of a behavior in a given situation
6. Intentions ... the conscious decision to perform a behavior or a resolve to act in a certain way
7. Memory, attention and decision
processes
... the ability to retain information, focus selectively on aspects of the environment and choose between two or more alternatives
8. Environmental context and resources ... any circumstance of a person’s situation or environment that discourages or encourages the development of skills and
abilities, independence, social competence, and adaptive behavior
9. Social influences ... those interpersonal processes that can cause individuals to change their thoughts, feelings, or behaviors
10. Emotion ... the complex reaction pattern, involving experiential, behavioral, and physiological elements, by which the individual attempts
to deal with a personally significant matter or event
11. Behavioral regulation ... anything aimed at managing or changing objectively observed or measured actions
than one way to target a single determinant. In a previous
review on patient determinants, the authors grouped similar
contents together and ended up with 40 heterogeneous umbrella
terms (Kardas et al., 2013). What appears nearly identical to our
42 patient determinants is slightly different, since no overlap
existed with our determinants for 6 of the 40 umbrella terms
(“Social stigma of disease”; “Prescription coverage”; “Prescription
by a specialist”; “Certain diagnoses/indications”; “Drug type,” and
“Well organized treatment”). A subset of patient determinants
must be considered unmodifiable, such as age, gender, or culture.
In our view, this distinction is essential for the choice of
adherence interventions. In order to be effective, we postulate
that interventions have on one hand to target current modifiable
patient determinants and on the other hand to be tailored to
the unmodifiable patient determinants. This lack of distinction
among the patient determinants in previous literature may
explain partly why no meta-analysis could demonstrate an
overall benefit of interventions aimed at enhancing adherence
(Nieuwlaat et al., 2014). Further research is needed to investigate
if adherence is improved when the intervention is matched to
the patient determinants for non-adherence according to our
matching list.
The importance of tailoring interventions to patient
characteristics has been acknowledged previously (Hugtenburg
et al., 2013; Linn et al., 2013; Müller et al., 2015). To
our knowledge, no published framework aimed to match
interventions and patient determinants of non-adherence.
Specific toolboxes for tailored interventions cover a restricted
number of interventions or patient determinants (Staring
et al., 2006; Herborg et al., 2008). Their intended use is the
application in daily practice where a workable toolbox trumps a
comprehensive framework. The 5 WHO dimensions that could
be used to classify both interventions and patient determinants
are too coarse to provide meaningful guidance (Sabaté, 2003).
The TDF has been the most recent and complete effort to
develop theory-informed behavior change interventions (French
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TABLE 3 | Matched adherence interventions and patient determinants according to 11 TDF categories.
Interventions Determinants (examples)
KNOWLEDGE
• Educate patients (Kripalani et al., 2007; Ryan et al., 2014)
◦ Provide information, e.g.,
• Provide copy of medical record (van Eijken et al., 2003)
• Provide medication charts/fact sheets (Schlenk et al., 2004; Haynes et al.,
2005, 2008; Ryan et al., 2014)
◦ Provide instruction, e.g.,
• Visual, verbal, written materials (van Eijken et al., 2003; Haynes et al.,
2005, 2008; Ryan et al., 2014)
• Self-help workbook (McDonald et al., 2002)
• Programmed learning (McDonald et al., 2002; Haynes et al., 2005, 2008)
• Adequate labeling (Vermeire et al., 2001)
• Icon-labeled medication containers (Banning, 2009)
• Harm-reduction training (Ryan et al., 2014)
• Counsel, give advice about treatment
◦ Benefits (Haynes et al., 2005, 2008; Kripalani et al., 2007)
◦ Importance (Haynes et al., 2005, 2008)
◦ Goal (Haynes et al., 2005, 2008)
◦ Mode of action (Haynes et al., 2005, 2008; Kripalani et al., 2007)
◦ Causes of low effect (Haynes et al., 2005, 2008)
◦ Correct use (of medication/device; Vermeire et al., 2001; Haynes et al., 2005,
2008; Kripalani et al., 2007; Ryan et al., 2014)
◦ Medication adherence (Haynes et al., 2005, 2008; Kripalani et al., 2007)
• Discuss knowledge about treatment (Ryan et al., 2014)
• knowledge about therapy and devices (Vlasnik et al., 2005; Baudrant-Boga et al.,
2012; know-how)
• Counsel, give advice about
◦ Target disease (Haynes et al., 2008)
◦ Symptoms (McDonald et al., 2002; Haynes et al., 2005, 2008; Kripalani
et al., 2007)
◦ Health (Haynes et al., 2005, 2008)
• Discuss knowledge about health (Ryan et al., 2014)
• Knowledge about illness (Vlasnik et al., 2005; Baudrant-Boga et al., 2012; insight
into the disease, understanding of the need for treatment)
SKILLS
• Swallowing training (Kripalani et al., 2007)
• Easy-to-use packaging (Vermeire et al., 2001)
• Physiotherapy (Haynes et al., 2005)
• Self-administration training (Ryan et al., 2014)
• Physical difficulties (Vlasnik et al., 2005; Baudrant-Boga et al., 2012; swallowing
difficulties, difficulties in handling small tablets or opening drug containers, visual
impairment)
• Self-management skills (Kripalani et al., 2007; Ryan et al., 2014)
• Problem-solving training (McDonald et al., 2002)
• Inpatient self-medication programs (Schlenk et al., 2004)
• Health literacy
• Communication skills training (Vermeire et al., 2001; Ryan et al., 2014) • Communication skills (Vlasnik et al., 2005; Schäfer-Keller et al., 2010;
Baudrant-Boga et al., 2012)
SOCIAL/PROFESSIONAL ROLE AND IDENTITY
• Contract (Kripalani et al., 2007)
• Improve relationship (Vermeire et al., 2001; Kripalani et al., 2007; Ryan et al.,
2014)
◦ consumer involvement
• Encouraging doctor-patient co-operation
• Patient-centeredness
• Taking into account of spiritual and psychological dimensions which may
be of primary importance to patients
• Accurate recognition of the patient’s problem by the health care provider
• Relationship patient—health care professional (Vlasnik et al., 2005; Schäfer-Keller
et al., 2010; Baudrant-Boga et al., 2012; Zeber et al., 2013; therapeutic alliance)
BELIEFS ABOUT CAPABILITIES
• Patient empowerment (Haynes et al., 2005, 2008; Kripalani et al., 2007) • Beliefs about self (Vlasnik et al., 2005; Baudrant-Boga et al., 2012; perceived
importance of self-care)
BELIEFS ABOUT CONSEQUENCES
• Cognitive restructuring (Haynes et al., 2005, 2008)
• Cognitive behavioral therapy (Kripalani et al., 2007; Haynes et al., 2008; Ryan
et al., 2014)
(Continued)
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TABLE 3 | Continued
Interventions Determinants (examples)
• Discuss
◦ Beliefs (Ryan et al., 2014)
◦ Barriers (Ryan et al., 2014)
◦ Ambivalence to treatment (Haynes et al., 2005, 2008)
◦ Adherence (Haynes et al., 2008)
• Beliefs about treatment (Vlasnik et al., 2005; Baudrant-Boga et al., 2012; Zeber
et al., 2013; faith in medication, concerns about taking drugs, fear of addiction,
preferences, perceived harms vs. benefits)
• Discuss
◦ Beliefs (Ryan et al., 2014)
◦ Barriers (Ryan et al., 2014)
◦ Stigma (Haynes et al., 2005, 2008)
• Beliefs about health (Vlasnik et al., 2005; Baudrant-Boga et al., 2012; Zeber
et al., 2013; anger, denial of the illness or its significance, apathy, confidence)
• Beliefs about health care system (Vlasnik et al., 2005; Zeber et al., 2013; trust in
health care system)
INTENTIONS
• Counseling about lifestyle (Kripalani et al., 2007)
◦ Diet (Schlenk et al., 2004; Haynes et al., 2005, 2008)
◦ Exercise (Haynes et al., 2005, 2008)
◦ Smoking (Haynes et al., 2005, 2008)
• Lifestyle (Vlasnik et al., 2005; Baudrant-Boga et al., 2012; Zeber et al., 2013;
stress, substance abuse, smoking, alcohol use)
• Rewards (McDonald et al., 2002; Haynes et al., 2005, 2008; Kripalani et al.,
2007; Nieuwlaat et al., 2014; Ryan et al., 2014)
◦ Material
◦ Monetary
• Motivational interviewing (Ryan et al., 2014)
• Action plans (Ryan et al., 2014)
• Motivation (Vlasnik et al., 2005; Ingersoll and Cohen, 2008; Schäfer-Keller et al.,
2010; Baudrant-Boga et al., 2012; readiness to change)
MEMORY, ATTENTION, AND DECISION PROCESSES
• Reminders
◦ Postcard (Ryan et al., 2014)
◦ Mailings (McDonald et al., 2002)
◦ Prescription refill (McDonald et al., 2002; Haynes et al., 2005, 2008)
◦ Telephone-linked computer system McDonald et al., 2002; van Eijken et al.,
2003; Haynes et al., 2005, 2008; Kripalani et al., 2007; Nieuwlaat et al.,
2014; Ryan et al., 2014)
◦ Appointment (McDonald et al., 2002; Haynes et al., 2005, 2008; Ryan et al.,
2014)
◦ Phone call (McDonald et al., 2002; van Eijken et al., 2003; Nieuwlaat et al.,
2014; Ryan et al., 2014)
◦ Mobile text messages (Nieuwlaat et al., 2014)
◦ Alarms (Ryan et al., 2014)
• Organizers (Vermeire et al., 2001; Ryan et al., 2014)
• Unit-of-use dispensing (Haynes et al., 2005, 2008)
• Automated dispenser (van Eijken et al., 2003)
• Directly observed therapy (Haynes et al., 2005, 2008; Kripalani et al., 2007; Ryan
et al., 2014)
• Patient diary (Kripalani et al., 2007; Nieuwlaat et al., 2014)
• Reminder pill packaging (Haynes et al., 2005, 2008; Kripalani et al., 2007; Ryan
et al., 2014)
• Disposing of excessive medication (Haynes et al., 2005, 2008; Kripalani et al.,
2007)
• Feedback on medication use (Vermeire et al., 2001; Haynes et al., 2005, 2008;
Kripalani et al., 2007)
• Forgetfulness (Vlasnik et al., 2005; Ingersoll and Cohen, 2008; Schäfer-Keller
et al., 2010)
ENVIRONMENTAL CONTEXT AND RESOURCES
Regimen
• Tailor treatment to daily habits (Vermeire et al., 2001; Schlenk et al., 2004;
Haynes et al., 2005, 2008)
• Simplified dosing regimens (Vermeire et al., 2001; Haynes et al., 2005; Kripalani
et al., 2007; Ryan et al., 2014)
• Intrusiveness (Ingersoll and Cohen, 2008; inconvenience, attention to routine)
• Reducing the frequency of dosing (Vermeire et al., 2001; Haynes et al., 2005,
2008; Kripalani et al., 2007; Ryan et al., 2014)
• Combination pills (Nieuwlaat et al., 2014)
• Pill burden (Vlasnik et al., 2005; Ingersoll and Cohen, 2008; Baudrant-Boga et al.,
2012; units per dose, doses per day)
(Continued)
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TABLE 3 | Continued
Interventions Determinants (examples)
• Changing the medication formulation (Haynes et al., 2005, 2008; Ryan et al.,
2014)
• Specificity of regimen (Vlasnik et al., 2005; Ingersoll and Cohen, 2008;
Baudrant-Boga et al., 2012; Zeber et al., 2013; time-dependence, storage and
food restrictions, formulation, time needed for treatment)
Adverse events
• Counseling
◦ Safety (Haynes et al., 2005, 2008)
◦ Adverse events (Kripalani et al., 2007; Haynes et al., 2008)
• Delayed antibiotic prescriptions (Ryan et al., 2014)
• Adverse events (Vlasnik et al., 2005; Ingersoll and Cohen, 2008; Schäfer-Keller
et al., 2010; Zeber et al., 2013; treatment-associated adverse reactions)
Integration and coordination of care
• Collaborative care (Vermeire et al., 2001; Banning, 2009)
• Reduced frequency of visits (Haynes et al., 2008)
• Liaising with general practitioner (Haynes et al., 2005, 2008)
• Pharmaceutical care services (Haynes et al., 2005, 2008; Ryan et al., 2014)
◦ Medicine reconciliation (Banning, 2009; Ryan et al., 2014) (recognition of
medication discrepancies)
◦ Medicines review (Ryan et al., 2014)
◦ Review illness history (Haynes et al., 2005, 2008)
◦ Care plan (Ryan et al., 2014)
◦ Multisystemic therapy (Haynes et al., 2008)
• clarify responsibility for administration of therapy (Vlasnik et al., 2005)
• Number of providers (Vlasnik et al., 2005; Ingersoll and Cohen, 2008; Zeber
et al., 2013)
• Increase the convenience of care (Haynes et al., 2005, 2008)
◦ Short waiting time (Vermeire et al., 2001)
◦ Short intervals between appointment (Vermeire et al., 2001)
• Provision of therapy at worksite (Haynes et al., 2005, 2008)
• Home visits (Kripalani et al., 2007; Ryan et al., 2014)
• Access to care (Vlasnik et al., 2005; Baudrant-Boga et al., 2012; Zeber et al.,
2013; difficulties in getting prescriptions filled, lack of transportation)
• Discharge planning (Banning, 2009)
• (Post-discharge) Follow-up (Schlenk et al., 2004; Haynes et al., 2005, 2008;
Ryan et al., 2014)
• Periodic reinforcement (Williams et al., 2008)
• Mass mailings (Ryan et al., 2014)
• Continuity of care (Baudrant-Boga et al., 2012)
• Remote internet-based treatment support (Nieuwlaat et al., 2014) • Availability of health care professionals (Schäfer-Keller et al., 2010;
Baudrant-Boga et al., 2012; overworked personnel, organization of care, quality
of care network)
• Prescribing errors (Zeber et al., 2013)
Financial aspects
• Financial incentives (Haynes et al., 2005, 2008; Ryan et al., 2014)
• Co-payments (Vermeire et al., 2001; McDonald et al., 2002; Ryan et al., 2014)
• Cost of treatment (Vlasnik et al., 2005; Schäfer-Keller et al., 2010; Zeber et al.,
2013; inability to afford medication, cost of care, out-of-pocket medication
expenses)
Social influences
• (Culturally modified) family intervention (McDonald et al., 2002; Haynes et al.,
2005, 2008; Kripalani et al., 2007; Ryan et al., 2014)
• Social support
◦ Lay health mentoring (Haynes et al., 2005, 2008)
◦ (Couple-focused) group programs (Haynes et al., 2005, 2008; Kripalani et al.,
2007; Ryan et al., 2014)
• Social/family support (Vlasnik et al., 2005; Baudrant-Boga et al., 2012; Zeber
et al., 2013; disrupted family structure)
EMOTION
• Psychological therapy (Haynes et al., 2005, 2008; Williams et al., 2008; Banning,
2009; Ryan et al., 2014; Nieuwlaat et al., 2014)
• Crisis intervention (Haynes et al., 2005, 2008)
• Psychological problems (Vlasnik et al., 2005; Ingersoll and Cohen, 2008;
Schäfer-Keller et al., 2010; Baudrant-Boga et al., 2012; depression, apathy,
psychosis)
BEHAVIORAL REGULATION
• Point-of-care testing (Kripalani et al., 2007)
• Self-monitoring
◦ Treatment (Haynes et al., 2005, 2008; Ryan et al., 2014)
◦ Symptoms (McDonald et al., 2002)
• Monitoring of treatment (Vlasnik et al., 2005)
Items were extracted from literature (103 interventions and 25 determinants). Examples and synonyms from the literature are given in brackets.
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et al., 2012) or assess the underlying theoretical constructs of
interventions (Little et al., 2015). Because it was not specifically
developed for interventions and patient determinants of non-
adherence, some adaption was warranted. While we were able
to assign all interventions and patient determinants to one
of the domains, we did not use 3 of the original 14 domains:
“Optimism,” “Reinforcement,” and “Goals”. “Optimism” (i.e., the
confidence that things will happen for the best or that desired
goals will be attained)may theoretically differ from beliefs, but we
chose not to differentiate between the two concepts for practical
reasons. By definition, “Reinforcement” (i.e., increasing the
probability of a response by arranging a dependent relationship,
or contingency, between the response and a given stimulus) can
only apply to interventions. Hence, we were not able to use this
domain for shared interventions and determinants. Instead, we
assigned interventions belonging to the “Reinforcement” domain
to “Intentions”. “Goals” (i.e., mental representations of outcomes
or end states that an individual wants to achieve) also overlaps
with “Intentions” and we chose not to differ between the two
concepts.
Some of the extracted interventions did not target
patient determinants. They represent much more unspecific
interventions such as general education to improve knowledge.
In contrast, one extracted determinant (Prescribing errors) could
not be matched to a specific intervention. Although, it is obvious
that studies to reduce prescribing errors were performed, they
may not have been aimed at enhancing adherence to treatment.
Our matching list allows for the assessment of congruency
between interventions and patient determinants in published
trials. Under the prerequisite that a causal relationship
exists between our interventions and corresponding patient
determinants, our list may help to assess the quality of published
studies and their results (Nieuwlaat et al., 2014). Furthermore,
our matching list may be useful to develop interventions and to
plan trials to assess the effectiveness of interventions with respect
to modifiable and unmodifiable patient determinants.
We acknowledge some limitations. First, we applied a very
specific search strategy to identify the most relevant literature.
A systematic approach with broader search terms and additional
databases might have yielded more articles, however, may
not have yielded additional items of interventions or patient
determinants. The 85% overlapping between our determinants
and those retrieved from a systematic review of reviews
(Kardas et al., 2013) reinforces this assumption. Second, we
did not consider the effectiveness of the interventions, the
frequency of the patient determinants, nor the impact size of
the patient determinants on adherence. Consequently, matching
interventions to patient determinants based on our results does
not guarantee for a successful adherence intervention. Other
concepts may be important to consider: determinants may be
different for each phase of medication adherence: initiation,
implementation, and persistence (Vrijens et al., 2012; Kardas
et al., 2013). The current literature lacks the information about
which determinant is associated to each of the three phases.
Third, our final matching list was not externally validated.
However and in line with others, the existence of ∼40 different
determinants seems plausible.
Our study has some strengths. First, we based our selection
on published models and theories, and previously proposed
categories. Consequently, our matching list represents a robust
framework in line with underlying theories. Second, reliability
was given from two independent investigators for extraction
and categorization reaching substantial agreement. Third, the
exclusion of reviews with focus on specific diseases, populations
or other criteria guarantees a broad applicability of the matching
list.
CONCLUSION
Matched interventions and patient determinants in common
categories are needed to assess the congruency between
interventions and patient determinants in published trials on
medication adherence. Our matching list may be useful to
develop interventions in trials that investigate the effectiveness
of adherence interventions. Application of this list will show
its practicability and may initiate its refinement and further
development into a practical tool. To be successful, interventions
in medication adherence should target current modifiable
patient determinants and be tailored to the unmodifiable
patient determinants. Modifiable and unmodifiable determinants
need to be assessed at inclusion of intervention studies
to identify the patients most in need of an adherence
intervention.
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